| Literature DB >> 21189848 |
Harshel G Parikh1, Sananta Kumar Dash, Chitra B Upasani.
Abstract
AIMS: To study the effect of oral gabapentin used as preemptive analgesia to attenuate post operative pain in patients undergoing abdominal surgery under general anesthesia.Entities:
Keywords: Abdominal surgery; gabapentin; post-operative pain; pre-emptive analgesia
Year: 2010 PMID: 21189848 PMCID: PMC2980657 DOI: 10.4103/1658-354X.71409
Source DB: PubMed Journal: Saudi J Anaesth
Independent t-test for equality of mean age in two study groups
| Group | N | Mean | SD | Df | Significance | ||
|---|---|---|---|---|---|---|---|
| Gabapentin 600 mg | 30 | 37.8 | 13.2 | −0.805 | 58 | 0.424 | Not significant |
| Control | 30 | 40.4 | 11.8 |
Comparison of sex distribution in two study groups
| Group | Treatment | Male (%) | Female (%) | Total |
|---|---|---|---|---|
| 1 | Gabapentin 600 mg | 12 (40) | 18 (60) | 30 |
| 2 | Control | 12 (40) | 18 (60) | 30 |
Chi-square test for comparison of sex in the study groups
| Pearson Chi-square | Value | df | Significance | |
|---|---|---|---|---|
| 0.000 | 1 | 1.000 | Not significant |
Independent t-test for equality of mean weight in the two study groups
| Group | N | Mean | SD | Df | Significance | ||
|---|---|---|---|---|---|---|---|
| Gabapentin 600 mg | 30 | 55.0 | 8.1 | 0.421 | 58 | 0.675 | Not significant |
| Control | 30 | 54.2 | 6.5 |
Independent t-test for equality of men duration of surgery in the two groups
| Group | N | Mean | SD | Df | Significance | ||
|---|---|---|---|---|---|---|---|
| Gabapentin 600 mg | 30 | 122.0 | 30.1 | 0.645 | 58 | 0.521 | Not significant |
| Control | 30 | 117.2 | 27.9 |
Independent t-test (mean dose of inj. Fentanyl in µg)
| Group | N | Mean | SD | Df | Significance | ||
|---|---|---|---|---|---|---|---|
| Gabapentin 600 mg | 30 | 146.3 | 32.3 | −0.258 | 58 | 0.798 | Not significant |
| Control | 30 | 148.3 | 27.7 |
Independent t-test (mean VAS)
| Vas | Group | N | Mean | SD | t | Df | Significance | |
|---|---|---|---|---|---|---|---|---|
| VAS 0 h | Gabapentin 600 mg | 30 | 1.9 | 0.7 | −3.227 | 58 | 0.002 | Significant |
| Control | 30 | 2.4 | 0.7 | |||||
| VAS 2 h | Gabapentin 600 mg | 30 | 2.3 | 0.7 | −3.928 | 58 | 0.000 | Significant |
| Control | 30 | 3.0 | 0.7 | |||||
| VAS 4 h | Gabapentin 600 mg | 30 | 3.2 | 0.8 | −2.850 | 58 | 0.006 | Significant |
| Control | 30 | 3.7 | 0.7 | |||||
| VAS 6 h | Gabapentin 600 mg | 30 | 2.9 | 0.7 | −9.050 | 58 | 0.000 | Significant |
| Control | 30 | 4.4 | 0.6 | |||||
| VAS 12 h | Gabapentin 600 mg | 30 | 3.6 | 0.6 | −6.530 | 58 | 0.000 | Significant |
| Control | 30 | 4.6 | 0.6 | |||||
| VAS 24 h | Gabapentin 600 mg | 30 | 3.7 | 0.7 | −5.046 | 58 | 0.000 | Significant |
| Control | 30 | 4.6 | 0.6 |
VAS: Visual analog score
Comparison of the VAS between the study groups (Repeated measure ANOVA)
| Vas | Gabapentin 600 mg | Control | |||||
|---|---|---|---|---|---|---|---|
| Mean | SD | Mean | SD | ||||
| VAS 0 h | 1.9 | 0.7 | 2.4 | 0.7 | |||
| VAS 2 h | 2.3 | 0.7 | 3.0 | 0.7 | |||
| VAS 4 h | 3.2 | 0.8 | 3.7 | 0.7 | |||
| VAS 6 h | 2.9 | 0.7 | 4.4 | 0.6 | |||
| VAS 12 h | 3.6 | 0.6 | 4.6 | 0.6 | |||
| VAS 24 h | 3.7 | 0.7 | 4.6 | 0.6 | |||
| 1 | Gabapentin 600 mg | 30 | 66.74 | 1 | 113.2 | 0.000 | Significant |
| 2 | Control | 30 | |||||
VAS: Visual analog score
Figure 1Graph comparing visual analog score in two groups
Rescue analgesia requirement in two study groups
| Group | Treatment | No (%) | Yes (%) | Total |
|---|---|---|---|---|
| 1 | Gabapentin 600 mg | 27 (90.00) | 3 (10.00) | 30 |
| 2 | Control | 17 (56.67) | 13 (43.33) | 30 |
Figures in parentheses are in percentage
Chi-square test for comparison of rescue analgesia in the study groups
| Pearson chi-square | Value | df | Significance | |
|---|---|---|---|---|
| 8.523 | 1 | 0.004 | Significant |
Figure 2Rescue analgesia requirement in both groups in post-operative period